Benzinga | Mar 2, 2021 05:11AM EST

Inovio Pharmaceuticals Awarded U.S. Patent 10,933,130 'Vaccines with interleukin-33 as an adjuvant'

Disclosed herein is a vaccine comprising an antigen and IL-33. Also disclosed herein is a method for increasing an immune response in a subject in need thereof. Further disclosed herein is a method for treating cancer in a subject in need thereof. The methods may comprise administering the vaccine to the subject.

View Patent Here